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ABSTRACT
The coiled-coil coactivator (CoCoA) is a transcrip-
tionalcoactivatorfornuclearreceptorsandenhances
nuclear receptor function by the interaction with
the bHLH-PAS domain (AD3) of p160 coactivators.
The C-terminal activation domain (AD) of CoCoA
possesses strong transactivation activity and is
required for the coactivator function of CoCoA with
nuclear receptors. To understand how CoCoA AD
transmits its activating signal to the transcription
machinery, we defined specific subregions, amino
acid motifs and protein binding partners involved
in the function of CoCoA AD. The minimal trans-
criptional AD was mapped to approximately 91
C-terminal amino acids and consists of acidic,
serine/proline-rich and phenylalanine-rich subdo-
mains. Transcriptional activation by the CoCoA AD
was p300-dependent, and p300 interacted physically
and functionally with CoCoA AD and was recruited
to a promoter by the interaction with CoCoA AD.
The FYDVASAF motif in the CoCoA AD was critical
for the transcriptional activity of CoCoA AD, the
interaction of CoCoA with p300, the coactivator
function of CoCoA for estrogen receptor a and
GRIP1 and the transcriptional synergy among
coactivators GRIP1, CARM1, p300 and CoCoA.
Taken together these data extend our understand-
ing of the mechanism of downstream signaling by
the essential C-terminal AD of the nuclear receptor
coactivator CoCoA; they indicate that p300 is a
functionally important interaction partner of CoCoA
AD and that their interaction potentiates transcrip-
tional activation by the p160 coactivator complex.
INTRODUCTION
The p160 transcriptional coactivators, GRIP1, SRC-1 and
AIB1, bind directly to nuclear receptors (NRs) and many
other types of transcription factors and serve as protein scaf-
folds for the assembly of multicomponent coactivator com-
plexes (1–3). The central NR interaction domain directly
binds to NRs (4). The C-terminal activation domains (AD),
AD1 (amino acids 1040–1120 of GRIP1) and AD2 (amino
acids 1122–1462 of GRIP1), recruit the histone acetyltrans-
ferases p300 and CBP and histone methyltransferases such
as CARM1 and PRMT1, respectively (5–8). These histone-
modifying enzymes act synergistically with p160 coactivators
to enhance NR function (7,9,10) and are recruited to the tar-
get gene promoters in a hormone-dependent manner (11–13).
The N-terminal AD, AD3 (amino acids 5–479 of GRIP1),
recruits the coiled-coil coactivator (CoCoA), GRIP1-
associated coactivator 63 (GAC63), Flightless I (Fli-I),
ankyrin repeats containing cofactor-1 (ANCO-1), BAF57
and MMS19 (14–19). CoCoA binds to the basic helix–loop–
helix/Per-Arnt-Sim (bHLH-PAS) domain (AD3) of p160
coactivators but not directly to NRs, and the coactivator activ-
ity of CoCoA for NRs is highly dependent on the presence of
a p160 coactivator. CoCoA cooperates synergistically with
GRIP1, CARM1 and p300 to enhance transcriptional activa-
tion by estrogen receptor (ER) a (15). In addition, CoCoA
binds to and cooperates synergistically with b-catenin as a
secondary coactivator for AR and TCF/LEF (20). Even though
CoCoA was initially identiﬁed as a secondary coactivator for
NRs, CoCoA binds directly to aryl hydrocarbon receptor
(AHR) and AHR nuclear translocator (ARNT) and serves
as a primary coactivator for AHR/ARNT (21). CoCoA is a
physiologically relevant part of several transcriptional activa-
tion processes. Endogenous CoCoA binds to the native pro-
moters of target genes for NR, AHR/ARNT and TCF/LEF
transcription factors and is required for efﬁcient ER, GRIP1,
AHR/ARNT, TCF/LEF and b-catenin function (15,20,21).
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doi:10.1093/nar/gkl361CoCoA has been dissected into several functional domains
that contribute to its coactivator activity (Figure 1A). The
central region (amino acids 150–500) of CoCoA contains
the coiled-coil domain that interacts with the bHLH-PAS
domains of p160 coactivators, AHR and ARNT (15,21).
Both the N-terminal (amino acids 1–190) and C-terminal
(amino acids 501–691) regions of CoCoA were capable of
binding to b-catenin (20). The C-terminal domain of
CoCoA possesses strong autonomous transcriptional activa-
tion activity when fused to the Gal4 DNA binding domain
and is essential for the coactivator function of CoCoA for
NRs, GRIP1 and AHR/ARNT (15,21). The AD of CoCoA
consists of 20% acidic amino acids, 24% serine and proline
(S/P) and 30% hydrophobic amino acids which are inter-
spersed with acidic residues (Figure 1A).
To activate the transcription of a particular gene, transcrip-
tional activators must orchestrate the assembly of transcrip-
tional complexes of numerous proteins. The transcriptional
ADs of transcription factors and coactivators interact with
distinct coregulators and many general transcription factors
to help assemble the basal transcription machinery (22,23).
Therefore, a better understanding of the mechanism of gene
regulation requires a precise delineation of these interactions.
Although a large number of transcriptional ADs are known,
these functional domains share little sequence homology
and have only loosely been classiﬁed by the preponderance
of amino acid residues such as glutamine, proline and acidic
residues (22,23). However, the most important amino acid
residues for transactivation are not necessarily the predomin-
ant residues such as glutamines or acidic amino acids.
Instead, in many cases, hydrophobic residues that are inter-
spersed with acidic amino acids appear to be important
elements for transactivation (24,25). Some ADs assume a
speciﬁc three-dimensional structure only upon binding
to an interaction partner, thus undergoing an induced ﬁt
(26–28). This low homology of ADs and their conforma-
tional ﬂexibility have made it difﬁcult to characterize these
essential domains in transcription factors and coactivators.
Figure 1. Fine mapping of the transcriptional AD of CoCoA. (A) Domain structure of CoCoA. The coiled-coil domain interacts with the bHLH-PAS domains of
transcriptional activators and coactivators. The function of the N-terminal domain (NTD) is unknown. The C-terminal 191 amino acids of CoCoA function as a
transcriptionalAD.TheCoCoAADconsistsofaphenylalanine(F)-richsubdomain,threeacidicsubdomainsandtwoserineandproline(S/P)-richsubdomains.Inthe
diagrams, numbers indicate CoCoA amino acid positions. (B) CV-1 cells in 12-well plates were transfected with GK1-LUC (200 ng) and a plasmid encoding Gal4
DBDorGal4DBDfusedtovariousCoCoAADfragments(200ng),asindicated.Luciferaseactivitywasmeasured48haftertransfection.Luciferaseactivityresults
shownare from a singleexperimentwhich is representative ofthree independentexperiments. Fold inductioncomparedwith Gal4 DBD is shownto the left of each
bar. (C) Expression levels of Gal4-CoCoA proteins. COS-7 cells were transfected with pM vectors encoding the indicated CoCoA fragment. Cell extracts were
subjected to immunoblot analysis with antibodies against the Gal4 DBD.
Nucleic Acids Research, 2006, Vol. 34, No. 9 2737Identiﬁcation of functional sequence motifs that are hidden in
ADs would help to dissect the functions of ADs and under-
stand their composite regulations.
To understand the function of CoCoA AD in the p160
coactivator complex and its mechanism of action, we charac-
terized CoCoA AD and identiﬁed important subregions and
amino acid motifs for its transactivation function. Deletions
and mutations of these motifs of CoCoA AD signiﬁcantly
reduced coactivator activity of CoCoA for GRIP1 and ER
and impaired synergy among GRIP1, CARM1, p300 and
CoCoA. Protein–protein interaction assays and chromatin
immunoprecipitation (ChIP) assays demonstrated that
CoCoA AD recruits p300. This interaction was essential for
transcriptional activation by CoCoA AD. Moreover, CoCoA
mediated the interaction between p300 and GRIP1 AD3.
Finally we demonstrated that CoCoA and p300 synergistic-
ally enhanced the transcriptional activity of GRIP1 AD3 in
a CoCoA AD-dependent manner. Our results suggest that




pSG5.HA-CoCoA, pSG5.HA-CoCoA 1–500, pSG5.HA-
CoCoA 150–500, pSG5.HA-CoCoA 150–691, pSG5.HA-
CoCoA 1–190, pSG5.HA-CoCoA 470–691, pSG5.
HA-GRIP1N (amino acids 5–479), pSG5.HA-GRIP1,
pSG5.HA-CARM1, pcDNA3.1-CoCoA/V5-HIS, pCMV-
p300, pM.CoCoA 501–691, pM.CoCoA 470–691,
pM.GRIP1N, pHE0 and GK1-LUC were described previ-
ously (15). The following plasmids were described previ-
ously as indicated: pGEX-p300-KIX, pGEX-p300-CH3,
pGEX-p300-Q, pGEX-p300-GBD, pGEX-p300-N, pGEX-
p300-C (29); pM.GRIP1 (30). PCR ampliﬁcation and sub-
cloning into the indicated restriction sites were performed
to create plasmids encoding the following CoCoA fragments
(with amino acid numbers): CoCoA 501–691, CoCoA 1–149,
CoCoA 274–510 into EcoRI and XhoI sites of pSG5.HA (8);
CoCoA 501–600, CoCoA 601–691 into EcoRI and XhoI sites
of pSG5.HA and EcoRI and SalI sites of pM (Clontech);
CoCoA 501–660, CoCoA 501–670, CoCoA 501–680,
CoCoA 551–691, CoCoA 631–691, CoCoA 661–691 into
EcoRI and SalI sites of pM; CoCoA 1–600 into XhoI and
BglII sites of pSG5.HA. Mutations were introduced in the
CoCoA cDNA by site-directed mutagenesis using the Quick-
Change II Site-Directed Mutagenesis Kit (Stratagene). The
sequences of oligonucleotides used for mutagenesis are
available upon request. p300 1155–1673 (HAT) was cloned
into EcoRI and XhoI sites of pGEX-5X-1 (Amersham). To
generate the 2ERE-TATA-LUC reporter plasmid, double
stranded oligonucleotides containing two ERE sequences
(15) and a minimal TATA sequence ( 42 to +14) of Xenopus
laevis vitellogenin B1 promoter were cloned into MluI and
XhoI sites and BglII and HindIII sites, respectively, of the
pGL3-basic vector (Promega). E1A and E1AD2-36 expres-
sion plasmids were kind gifts from Fang Liu (State Univer-
sity of New Jersey) (31). pCI-FLAG-p300 and its DHAT
mutant expression plasmids, pCI-FLAG-p300D1472-1522
and pCI-FLAG-p300D1603-1653, were kindly provided by
Yoshihiro Nakatani (Harvard University) (32). pcDNA3.1-
HDAC1.Myc and pcDNA3.1-HDAC4.Myc were kindly pro-
vided by Mitchell A. Lazar (University of Pennsylvania) (33).
Cell Culture and Transient Transfection
CV-1, COS-7, HEK 293T and HLR cells were grown in
DMEM with 10% fetal bovine serum. For reporter gene
assays, CV-1 cells were plated at 5 · 10
4 or 1 · 10
5 cells/
well in 24-well or 12-well plates, respectively, and transiently
transfected by TargeFect F1 reagent (Targeting Systems).
Total amount of plasmid DNA added to each well was adjus-
ted to 0.6 or 1.0 mg by adding the necessary amount of
pSG5.HA empty vector. For ER experiments, after transfec-
tion, cells were incubated in phenol red-free DMEM contain-
ing 5% fetal bovine serum treated with dextran-coated
charcoal (Gemini Bioproducts), 20 mM Na-HEPES, pH 7.2,
penicillin and streptomycin, with or without 100 nM E2.
Cell extracts were prepared and assayed for luciferase activity
48 h after transfection, as described previously (15). HEK
293T cells were transiently transfected using Lipofectamine
2000 (Invitrogen) as described previously (21). The results
shown are the means and SD of triplicate points. Instead of
using internal controls, results shown are representative of
multiple independent experiments, as indicated in ﬁgure
legends.
Histone Acetyltrasferase (HAT) assay
COS-7 cells were transfected with pSG5.HA-CoCoA or
pSG.HA-CoCoA 470–691. HA-tagged CoCoA and CoCoA
470–691 expressed in COS-7 cells were immunoprecipitated
with 1 mg anti-HA antibody 3F10 (Roche) and 20 ml protein
A/G agarose suspension (Santa Cruz Biotechnology).
Immunoprecipitates were incubated at 30 C for 1 h with
5 mg calf thymus core histones (type IIA, Sigma) and
0.5 mCi [
3H]-acetyl-CoA (Amersham) in buffer containing
50 mM Tris–HCl (pH8.0), 30 mM KCl, 10% glycerol,
10 mM sodium butyrate, 1 mM DTT in a total volume of
30 ml. Reactions were stopped by adding 4· SDS sample
buffer and fractionated on 15% SDS–PAGE gels. Gels were
ﬁxed with 50% (vol/vol) methanol-10% (vol/vol) acetic acid
for 30 min, then soaked with Amplify (Amersham) for
30 min, and vacuum dried. Fluorography was performed
overnight.
Coimmunoprecipitation and immunoblotting
COS-7 or HEK 293T cell transfection, coimmunoprecipita-
tion (CoIP) and immunoblotting were performed as described
previously (15,21). For CoIP, cell lysate containing 1 mg of
protein was incubated with 1 mg of the anti-p300 antibody
RW128 (Upstate) or 1 mg of mouse normal IgG (Santa
Cruz Biotechnology) and 20 ml of protein A/G agarose sus-
pension or 20 ml of Ni-NTA HIS-Bind agarose (Novagen)
overnight at 4 C. Immunoblots were then performed on the
precipitated proteins with anti-HA antibody 3F10, anti-p300
antibody RW128 or anti-V5 antibody R960-25 (Invitrogen).
Gal4 DBD fusion proteins were detected using an anti-Gal4
DBD antibody (Upstate).
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HA or V5 epitope-tagged CoCoA and its fragments were syn-
thesized in vitro using TNT-Quick coupled transcription/
translation system (Promega) according to the manufacturer’s
protocol. GST pull-down assays were performed as described
previously (15,21). GST fusion proteins were expressed in
Echerichia coli BL21 and bound to glutathione-Sepharose-
4B beads (Amersham Pharmacia). Bound proteins were
analyzed by immunoblot with anti-HA antibody or anti-V5
antibody R960-25.
Chromatin immunoprecipitation and reporter
coimmunoprecipitation
HLR cells (Stratagene) with stably integrated Gal4-LUC
reporter (pFR-LUC) in 150 mm dishes were transiently trans-
fected with pM or pM.CoCoA 501–691 (8 mg) using Lipo-
fectamine 2000. ChIP assays were performed largely as
described previously (15,21). After 48 h transfection, the
cross-linked, sheared chromatin solution was used for
immunoprecipitation with 1 mg of anti-Gal4 antibody
06–262 (Upstate), 1 mg of anti-p300 antibody RW128, or
1 mg of mouse normal IgG. The immunoprecipitated DNAs
were puriﬁed by phenol–chloroform extraction, precipitated
by ethanol and ampliﬁed by PCR using primers
ﬂanking the Gal4 responsive elements: 50-GGTAC-
CGAGCTCGAATTCCAGCTT-30 (forward) and 50-GCGT-
ATCTCTTCATAGCCTTATGC-30 (reverse). Quantitative
real-time PCR (qPCR) was performed with Brilliant SYBR
Green QPCR Master Mix according to the manufacturer’s
instructions (Stratagene). The qPCR conditions were identical
to the standard PCR. Reporter Co-IP assays were performed
as described previously (15,34). COS-7 cells in 100 mm
dishes were transfected with pG5-LUC (Promega) and
pGL3-Basic (Promega) reporter plasmids and Gal4 DBD or
Gal4-CoCoA 501–691 expression plasmids as indicated in
ﬁgure legend. Soluble chromatin fraction was prepared and
immunoprecipitated, and PCR was performed as described
previously (15,34). The following primers spanning the Gal4
responsive elements of pG5-LUC reporter were used for
PCR ampliﬁcation: 50-CAAGTGCAGGTGCCAGAACA-30
(forward) and 50-CCACCTCGATATGTGCATCTGT-30
(reverse). The amount of each immunoprecipitated DNA
sample was titrated to determine the linear range for the
PCR reactions, and the results shown are within the linear
range.
RESULTS
Fine mapping of CoCoA AD
The transcriptional AD of CoCoA was mapped to amino
acids 501–691 in our previous study (Figure 1A) (15). To fur-
ther deﬁne the CoCoA transcriptional AD more precisely,
progressive N-terminal or C-terminal deletions were intro-
duced in the C-terminal AD of CoCoA. Various regions in
CoCoA AD were fused to the Gal4 DBD and fusion con-
structs were cotransfected with a reporter plasmid carrying
Gal4 responsive elements. The C-terminal AD (amino acids
501–691) of CoCoA showed strong transactivation activity
(Figure 1B, assay 2). A mutant with a deletion of 50 amino
acids from the N-terminus of CoCoA AD retained wild-
type activity (Gal4-CoCoA 551–691) (assay 3). Further
deletion of the N-terminal sequences sharply reduced the
transactivating potential of CoCoA AD. However, although
Gal4-CoCoA 601–691 and Gal4-CoCoA 631–691 lost  60
and 80%, respectively, of the wild-type CoCoA AD activity
(assays 4–5), we still observed  400-fold and 200-fold
stimulation of reporter gene activity. Gal4-CoCoA 661–691
showed a nearly 95% loss of function (assay 6). Interestingly,
deletion of 11 amino acids (681–691) from the extreme C-
terminus, leaving Gal4-CoCoA 501–680, almost abolished
strong transactivation activity, and further deletion up to
660 (leaving Gal4-CoCoA 501–660) had no further effect
(assays 7–9). Further deletion of an additional 60 amino
acids (Gal4-CoCoA 501–600) virtually abolished the
transcriptional potential of CoCoA AD (assay 10). All of
the fusion proteins were expressed at similar levels
(Figure 1C). These results suggest that the transactivation
ability of CoCoA is primarily contained within the residues
601–691 (the minimal or core AD) and that this minimal
AD can be divided into two subdomains, amino acids 601–
660 (acidic/S/P-rich subdomain) and amino acids 661–691
(acidic/F-rich subdomain) (Figure 1A). The combination
(core AD) of these two subdomains can synergistically activ-
ate transcription (assays 4, 6 and 9). The residues 501–600
may be a subdomain that can affect the degree of CoCoA
transactivation activity. In addition, the results show that
the last 11 amino acids (F-rich region) of CoCoA are essential
for its strong transcriptional activity.
CoCoA is associated with p300
To investigate the mechanism through which CoCoA activ-
ates transcription and identify proteins capable of interacting
with CoCoA AD, we tested whether CoCoA is associated
with histone-modifying enzymes. We performed histone
acetyltransferase (HAT) assays using HA-tagged CoCoA
and CoCoA 470–691 fragment immunoprecipitated with
anti-HA antibody from COS-7 cell extracts. The anti-HA
immunoprecipitates from HA-CoCoA and HA-CoCoA 470–
691 transfected cells had higher levels of HAT activity, com-
pared with similar immunoprecipitates from control cells
transfected with pSG5.HA empty vector (Figure 2A). This
observation suggests that CoCoA physically associates with
an HAT activity. The bacterially expressed GST-CoCoA
and GST-CoCoA 470–691 did not harbor any intrinsic
HAT activity (data not shown), suggesting that CoCoA is
not an HAT by itself.
To test whether CoCoA can interact with p300 in cells,
COS-7 cells were transfected with CoCoA-His and p300,
and cell lysates were pulled down with Ni-bound agarose
or agarose beads, followed by immunoblotting analysis with
anti-p300 antibody. p300 was identiﬁed along with CoCoA
among the proteins pelleted by Ni-agarose beads but not by
control agarose beads (Figure 2B). Similar data were obtained
with p300 and CoCoA-His in HEK 293T cells (data not
shown). In a reciprocal experiment, p300 was transfected
into COS-7 cells alone or in combination with HA-CoCoA,
and CoCoA was coimmunoprecipitated speciﬁcally with
p300 (Figure 2C). These results indicate that CoCoA can
physically interact with p300 in vivo.
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To identify the part(s) of p300 that can interact with CoCoA,
the N-terminal, KIX, HAT and C-terminal domains of p300
(Figure 3A) were expressed as GST fusion proteins in
E.coli, puriﬁed, and incubated with in vitro translated
CoCoA. GST-p300 KIX and GST-p300 C bound efﬁciently
to CoCoA, whereas GST-p300 N and GST-p300 HAT failed
to do so (Figure 3B). Next, we scanned the p300 C-terminal
fragment for interaction with CoCoA using three GST-p300
fusion proteins encoding CH3, GBD (GRIP1 binding domain)
and Q-rich regions (Figure 3A). Although the p300 Q-rich
region possessed marginal binding activity, CH3 domain
bound with greater efﬁciency to CoCoA (Figure 3C). These
results indicate that p300 contains two main regions, KIX
and CH3, which can bind to CoCoA.
Using similar approaches, we investigated the region in
CoCoA that is required for the interaction with p300. While
CoCoA AD (amino acids 501–691) and the N-terminal
domain (amino acids 1–190) were able to bind p300 KIX
and CH3 domains, CoCoA coiled-coil domain (amino acids
150–500) failed to interact with p300 KIX and CH3 domains
(Figure 3D and E). These results therefore suggest that
CoCoA contains at least two autonomous and separable inter-
action domains for p300. In these assays, CoCoA fragments
were capable of interacting with p300 as long as they con-
tained at least the C-terminal AD. Interestingly, the coiled-
coil domain (amino acids 150–500) negatively regulated the
interaction between the N-terminal domain of CoCoA and
p300, while it did not affect CoCoA AD binding to p300
(Figure 3D and E). The core AD (CoCoA 601–691) itself
still interacted strongly with p300 (Figure 3F). However,
deletion of the core AD drastically reduced p300 KIX inter-
action relative to the full length (amino acids 501–691) and
core (amino acids 601–691) ADs but did not abrogate it
(Figure 3D). Thus, the core AD is required and sufﬁcient
for the interaction with p300. The control GST alone failed
to bind any of the in vitro translated proteins. Therefore,
p300 KIX and CH3 domains interact with CoCoA AD, and
the core AD is important for that interaction. Thus, the
major p300 binding domain of CoCoA (deﬁned in
Figure 3) co-localizes with the core AD (deﬁned in
Figure 1B). Taken together, our data show that CoCoA dir-
ectly interacts with KIX and CH3 domains of p300 and that
CoCoA domains involved in the interaction with p300 are
distinct from the GRIP1-binding domain in the coiled-coil
region.
Endogenous p300 is required for the transcriptional
activity of CoCoA AD
As an initial test of p300 dependence, we tested the effects
of p300 expression on the ability of CoCoA AD to activate
transcription in a mammalian one-hybrid assay (Figure 4A).
A p300 expression plasmid was cotransfected with various
Gal4-CoCoA AD expression plasmids into 293T cells. In
these assays, p300 activated CoCoA AD-mediated transcrip-
tional activation about 5-fold (assays 6). However, coexpres-
sion of the coactivator PCAF had no apparent effect (data not
shown). The transcriptional activity mediated by CoCoA
501–680, CoCoA 501–660 or CoCoA 661–691 was also
enhanced by p300 about 16-fold, 15-fold and 8-fold, respect-
ively (assays 2, 3 and 5). In contrast, p300 had a minimal
effect ( 2-fold) on the transcriptional activity of Gal4
alone or Gal4-CoCoA 501–600 lacking core AD (assays
1 and 4). These results suggest functional interaction between
Figure 2. CoCoA is associated with p300. (A) CoCoA is associated with HAT
activity. COS-7 cells were transfected with pSG5.HA-CoCoA, pSG5.HA-
CoCoA 470–691 or pSG5.HA (3 mg) and immunoprecipitated with 1 mgo f
anti-HA antibody. Immunoprecipitates were assayed for HAT activity using
5mgofcore histones.Ofimmunoprecipitatedsamples50%werealsoanalyzed
by western blotting using the anti-HA antibody to detect immunoprecipitated
CoCoA proteins. IgG-H, immunoglobulin G heavy chain from the immuno-
precipitation. These results were reproducible from three independent experi-
ments. (B) Interaction of CoCoA with p300 in vivo. COS-7 cells were
transfected with pcDNA3.1-CoCoA.V5/HIS (3 mg) and pCMV-p300 (6 mg).
Cell extracts were prepared 48 h after transfection and incubated with Ni-NTA
HIS-Bind agarose beads or control agarose beads. Bound CoCoA-V5/HIS and
coprecipitated p300 proteins were detected by immunoblot analysis with anti-
V5 antibody or anti-p300 antibody. A portion of the original cell extract was
also examined for CoCoA and p300 expression (5% input). (C) COS-7 cells
were transfected with pCMV-p300 (6 mg) either alone or together with pSG5-
HA.CoCoA (3 mg). Cell lysates were immunoprecipitated (IP) with anti-p300
antibody (v and vi) or control normal mouse IgG (iii and iv). Immunopreci-
pitated p300 (v) and coimmunoprecipitated HA-CoCoA (vi) were detected by
immunoblotting (IB) with anti-p300 or anti-HA antibodies. A portion of the
original cell extract was also examined for CoCoA and p300 expression (5%
input, i and ii).
2740 Nucleic Acids Research, 2006, Vol. 34, No. 9CoCoA AD and p300 and demonstrate that the core AD
(amino acids 601–691) of CoCoA AD is essential for the
ability of CoCoA AD to be enhanced by p300.
To assess the role of endogenous p300/CBP in transcrip-
tional activation by CoCoA AD, we used the p300/CBP
inhibitor E1A. This viral protein inhibits p300/CBP-
dependent transactivation by a number of transcription
factors that interact with p300/CBP (35,36). To investigate
whether E1A interferes with CoCoA AD-mediated transcrip-
tion, we performed mammalian one-hybrid assays using
Gal4-CoCoA 501–691 and E1A constructs in 293T cells
(Figure 4B). The wild-type E1A repressed CoCoA AD activ-
ity in a dose-dependent manner (assays 2–5). In contrast, the
mutant E1AD2-36, which lacks the interaction domain for
p300/CBP, had no signiﬁcant inhibitory effect on the tran-
scriptional activity of CoCoA AD (assays 6–9), while the
expression level of the mutant was even higher than that of
wild-type E1A (Figure 4D). The inhibitory effect of E1A
on CoCoA AD-mediated transcription indicated that endo-
genous p300 may be involved in this process.
Figure 3. DomainrequirementsforCoCoAandp300interaction.(A)Schematicrepresentationofp300-derivedproteinfragmentsfusedto GST.(BandC) CoCoA
interacts with KIX and CH3 regions of p300. Equal amounts of various GST-fusion fragments of p300 were incubated with in vitro translated V5- or HA-tagged
CoCoA.Boundproteinswereanalyzedbyimmunoblotanalysiswithanti-V5oranti-HAantibodies.Aportionofinvitrotranslatedproteinwasloadeddirectly(10%
input).(D)InteractionofCoCoAwiththeKIXdomainofp300invitro.HA-taggedCoCoAfragmentssynthesizedinvitrowereincubatedwithequalamountsofGST
or GST-KIXfusion protein. Bound proteins were analyzed by immunoblot with anti-HA antibody.A portionof in vitro translatedprotein was loadeddirectly (10%
input).(E)InteractionofCoCoAwiththeCH3domainofp300invitro.GSTpull-downassayswereperformedasdescribeaboveusinginvitrotranslatedCoCoAor
itsfragmentsandGSTorGST-CH3boundtobeads.(F)CoreADofCoCoAinteractswithKIXandCH3regionsofp300.GSTpull-downassayswereperformedas
described above using in vitro translated CoCoA 601–691 and GST, GST-KIX or GST-CH3 bound to beads.
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sary to enhance CoCoA AD activity and whether p300 can
rescue E1A-mediated repression (Figure 4C). Again, expres-
sion of p300 enhanced the transcriptional activity of CoCoA
AD (assay 2). In contrast, no signiﬁcant enhancement was
observed when p300DHAT mutants were expressed (assays
3–6), while mutant and wild-type p300s were expressed at
similar levels when 100 ng of wild-type p300 and 200 ng
of p300 DHAT mutants were used in the transfection experi-
ment (Figure 4D). Interestingly, although p300 rescued E1A-
mediated repression (assay 8), p300DHAT mutants failed
to rescue CoCoA AD activity (assays 9–12). Thus, the
HAT activity of p300 is essential for its ability to poten-
tiate transcriptional activation mediated by CoCoA AD.
Overall, these results demonstrate that the interaction with
enzymatically active p300 is important for and correlates
with the transactivation activity of CoCoA AD.
Endogenous p300 is recruited to the promoter by
CoCoA AD
A modiﬁed ChIP experiment (reporter CoIP) was performed
to test whether endogenous p300 participates in the trans-
criptional activation by CoCoA AD. COS-7 cells were
transfected with pG5-LUC reporter plasmid and Gal4 DBD
or Gal4-CoCoA AD expression vector. As an internal
control, the pGL3-Basic reporter plasmid, which has the
same plasmid backbone as pG5-LUC but no Gal4 response
elements, was also included in the transfection. The cross-
linked and sheared nuclear fractions were subjected to
Figure 4. Requirement of p300 for the transactivation activity of CoCoA AD. (A) p300 enhances the transactivation activity of CoCoA AD. 293T cells in 24-well
plates were transfected with GK1-LUC (100 ng), plasmids encoding Gal4 DBD or Gal4-CoCoA AD fragments (100 ng), and pCMV-p300 (100 ng), as indicated.
Luciferase activitywasmeasured 24 h after transfection. Luciferaseactivity resultsshownare from a single experiment which is representative of fourindependent
experiments.(B) AdenovirusE1AexpressioninhibitsCoCoAAD-mediatedtransactivation.293Tcellsin24-wellplatesweretransfectedwithGK1-LUC(100ng),
Gal4-CoCoA501–691(100ng),andvariableamountsofE1Aexpressionplasmids(25,50,100and200ng),asindicated.Luciferaseactivitywasmeasured24hafter
transfection. Luciferase activity results shown are from a single experiment which is representative of four independent experiments. (C) HAT activity of p300 is
requiredforitsfunctionascoactivatorofCoCoAAD.TransienttransfectionsusingpCI-FLAG-p300(100ng)orpCI-FLAG-p300DHATmutants(+,100ngand++,
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ies, and the precipitated DNA was analyzed by PCR ampli-
ﬁcation using primers against sequences on the backbone of
the pGL3-Basic reporter plasmid. PCR ampliﬁcation using
these primers produces a 406 bp product from the pG5-
LUC reporter and a 269 bp product from the pGL3-Basic
reporter (Figure 5A). Similar input PCR signals were gener-
ated from pG5-LUC and pGL3-Basic reporters, indicating
similar amounts of the two reporters in the transfected
COS-7 cells. Gal4 DBD only and Gal4-CoCoA AD were
preferentially recruited to the pG5-LUC reporter containing
the Gal4 responsive elements. However, preferential recruit-
ment of endogenous p300 to the pG5-LUC reporter was
observed only in the presence of Gal4-CoCoA AD, compared
with the p300 recruitment to the pG5-LUC reporter in the
COS-7 cells transfected with the Gal4 DBD expression vec-
tor. A no-antibody control showed equal low background
levels of both plasmids. Therefore, endogenous p300 is spe-
ciﬁcally recruited to the Gal4 responsive elements through
the interaction with Gal4-CoCoA AD.
To further investigate whether endogenous p300 is
recruited to a chromosomally integrated Gal4-regulated pro-
moter through the interaction with CoCoA AD, we used a
HeLa cell line (HLR) harboring a stably integrated reporter
gene controlled by 5 Gal4 response elements (pFR-LUC).
HLR cells transfected with Gal4 DBD or Gal4-CoCoA AD
expression vector were analyzed by the ChIP assay. Consist-
ent with our reporter CoIP data, occupancy at Gal4 response
elements was similar for Gal4 DBD only and Gal4-CoCoA
AD; however, endogenous p300 was speciﬁcally recruited
to the integrated Gal4 responsive elements in a CoCoA
AD-dependent manner (Figure 5B). By quantitative real-
time PCR analysis we observed a 5-fold increase in p300
recruitment to Gal4 responsive elements by Gal4-CoCoA
AD, compared with Gal4 DBD alone, even though Gal4
DBD and Gal4-CoCoA AD were recruited to the Gal4
responsive elements with equal efﬁciency (Figure 5C).
Thus, endogenous p300 is recruited to promoter-bound
CoCoA AD, demonstrating a functional interaction between
p300 and CoCoA AD occurring in an in vivo setting. Our
reporter CoIP and ChIP data indicate that strong transactiva-
tion activity of CoCoA AD in mammalian one hybrid assays
correlates with the recruitment of endogenous p300 to
CoCoA AD.
HDACs negatively regulate CoCoA AD-mediated
transcription
The acetyltransferase activity of p300 is necessary to potenti-
ate CoCoA AD activity (Figure 4C). We therefore investig-
ated the functional impact of the HDAC inhibitor
trichostatin A (TSA) and overexpression of HDACs on the
transcriptional activity of CoCoA AD. TSA treatment aug-
mented the transcriptional activity of Gal4-CoCoA AD
fragments containing the core AD (Figure 6A, assays 2,
3 and 5). In contrast, the activity of Gal4 DBD only and Gal4-
CoCoA 501–600 lacking the Core AD was only marginally
Figure 5. Specific recruitment of endogenous p300 to Gal4 responsive
promoters by Gal4-CoCoA AD (501–691). (A) Recruitment to the transiently
transfected Gal4 responsive promoter. COS-7 cells in 100 mm dishes were
transfected with pG5-LUC (3 mg), pGL3-Basic (3 mg) and pM or pM.CoCoA
501–691(3mg).After48htransfection,crosslinked,sonicatednuclearextracts
were immunoprecipitated with the indicated antibodies. PCR analysis was
performed with primers that recognize identical backbone sequences in both
reporter plasmids but produce different size PCR products from the two
reporters, as illustrated in the diagram. The data shown were obtained with
0.1 ml of input DNA and 1 ml of precipitated DNA samples. Results shown are
representative of three independent experiments. (B) Occupancy of the stably
integrated Gal4 responsive promoter.HLR cells, containinga stably integrated
Gal4-LUC reporter gene, were transiently transfected in 150 mm dishes with
pM or pM.CoCoA 501–691 (8 mg). After 48 h transfection, crosslinked, soni-
cated nuclear extracts were immunoprecipitated with the indicated antibodies.
The coprecipitated DNA was amplified by PCR using primers to amplify the
Gal4 responsive promoter. PCR was performed with varying amounts of input
(1, 0.1 and 0.01 ml) and precipitated DNA samples (5, 2.5, 1 and 0.2 ml) to
determine the linear range for the amplification (data not shown). The data
shown were obtained with 0.1 or 1 ml of input DNA and 1 or 2.5 ml of pre-
cipitatedDNAsamples.PositionofthePCRprimersamplifyinga regionofthe
Gal4 responsive promoter is indicated by the opposing pair of arrows in the
diagram.Theresultsshownarerepresentativeoftwoindependentexperiments.
(C) Real-timePCR analysiswasperformedwiththe same primersand samples
usedin(B).Thedatashownwereobtainedwith1mlofinputand1mlor2.5mlof
precipitated DNA samples (1 mlo fa-Gal4 samples and 2.5 mlo fa-p300 and
IgGsamples).Theresultsareshownaspercentageofinputandarethemeanand
SD from triplicate reactions.
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ults, overexpression of HDAC1 and HDAC4, either alone or
together, led to the inhibition of the transcriptional activity of
CoCoA AD (Figure 6B). These data suggest that HDACs can
repress the transcriptional activity of CoCoA AD, and again
that endogenous HAT activity is required for CoCoA AD
activity.
Mutational analysis of FXXFFXXF motif in
the Core AD
The core AD of CoCoA contains a stretch of amino acids
FYDVASAF which ﬁts a consensus sequence (F/YXX-
FFXXF, where X represents any amino acid and F repres-
ents any hydrophobic amino acid) shown to be important for
the transcriptional activation function of several transcrip-
tion factors and for their interaction with p300 KIX (37).
This consensus sequence is highly conserved in CoCoA pro-
teins of various species (Figure 7A). This motif is found in
the ADs of p53, VP16, CREB and p65 (26,37–39). The
relative importance of the putative KIX binding motif was
examined by testing the effects of mutations in the core
AD on its transcriptional activity in mammalian one-hybrid
assays and its interaction with KIX and CH3 domains of
p300 in GST pull-down assays. Secondary structure analysis
using the HNN (hierarchial neural network) method (40)
predicts that FYDVASAF motif of CoCoA AD has the
potential to form an a-helical structure. The projection of
residues 628–635 of core AD onto a helical wheel reveals
that three hydrophobic residues, Phe-628, Val-631 and
Phe-635, lie along one face of the helix (Figure 7B).
These three residues were replaced with Ala (F628A,
F628A/V631A and F628/635A). To disrupt the a-helix
formation in another mutant, Asp-630, which is located on
the other side of the helix, was substituted with helix break-
ing Pro (D630P). To analyze transactivation potential, each
CoCoA AD point mutant was fused with Gal4 DBD, and its
expression plasmid was transfected into CV-1 cells with a
Gal4-responsive reporter plasmid. All of the fusion proteins
were expressed at similar levels (Figure 7D). Mutations
F628A, D630P and F628A/V631A resulted in a reproducible
reduction ( 40–60%) in the level of transcriptional activity
in mammalian one-hybrid assays, indicating that the helical
structure and hydrophobic residues in the putative KIX
binding motif are important for the transactivation activity
of CoCoA AD (Figure 7C). Double mutation F628/635A
more severely impaired the transactivation activity of
CoCoA AD, demonstrating the critical role of these
phenylalanine residues in creating a fully functional AD.
To determine whether the reduced transactivation poten-
tial of F628/635A mutant was paralleled by a reduction in
physical interaction with p300, we performed GST pull-
down experiments with p300 CH3 and KIX fragments
fused to GST and in vitro translated CoCoA proteins. In
low salt concentration (200 mM NaCl), the F628/635A
mutant still retained its ability to bind p300 (data not
shown). However, at a higher salt concentration (300 mM
NaCl) wild-type CoCoA still strongly interacted with CH3
and KIX domains of p300, but little or no interaction
above background was observed with the F628/635A mutant
(Figure 7E). Thus, the two phenylalanine residues in the
FYDVASAF motif of CoCoA AD are critical for high afﬁn-
ity interaction with the KIX and CH3 domains of p300.
Taken together, these results suggest that the helical
FYDVASAF motif of CoCoA AD contributes to the interac-
tion with p300, and that CoCoA-p300 interaction contributes
to the transcriptional activity of CoCoA AD.
TheC-terminalADofCoCoAisrequiredforcoactivator
function of CoCoA and synergistic activation of
ER function
We have previously shown that CoCoA functions as a
secondary coactivator in transient transfection assays using
Figure6.HDACsrepressCoCoAADactivity.(A)TSAenhancesthetransactivationactivityofCoCoAAD.CV-1cellsin12-wellplatesweretransfectedwithGK1-
LUC (200 ng) and plasmids encoding Gal4 DBD or Gal4-CoCoA AD fragments (200 ng), as indicated. Cells were treated with 100 nM TSA for 18 h before
harvesting. Luciferase activity was measured 48 h after transfection. Luciferase activity results shownare from a single experiment which is representative of three
independentexperiments.FoldinductionbyTSAisshownattheleftofeachpairofbars.(B)CV-1cellsweretransfectedwithGK1-LUC(200ng),plasmidsencoding
Gal4-CoCoA501–691orGal4–CoCoA601–691(200ng)andHDACexpressionplasmids(200ng),asindicated.Luciferaseactivityresultsshownarefromasingle
experiment which is representative of two independent experiments.
2744 Nucleic Acids Research, 2006, Vol. 34, No. 9relatively high level ER conditions. Furthermore, at low ER
levels which allow synergy among three or more coactivators
to be observed (10), GRIP1, CoCoA, p300 and CARM1
enhanced ER function in a synergistic manner (15). In our
previous studies the C-terminal AD of CoCoA was required
for CoCoA coactivator function to enhance the transcriptional
activity of the bHLH-PAS domain of GRIP1 or AHR (15,21).
We ﬁrst examined the effect of the deletion and mutations of
the C-terminal AD of CoCoA on its coactivator function at a
high level of ER (Figure 8A). Full length CoCoA potentiated
ER activity in the presence of GRIP1 (assays 4–5), as previ-
ously shown (15). In contrast, the coactivator activity of
CoCoA was severely impaired by deletion of the core AD
or point mutations in the FYDVASAF motif (assays 6–17).
All of the CoCoA proteins were expressed at similar levels
(data not shown).
To conﬁrm that the core AD of CoCoA is necessary for its
coactivator function, we next tested the effect of CoCoA or
its AD deletion and point mutants on the transcriptional
activation function of GRIP1 in a mammalian one-hybrid sys-
tem (Figure 8B). The modest transcriptional activation func-
tion of GRIP1 fused to Gal4 DBD was strongly stimulated by
wild-type CoCoA (assay 4). In contrast, deletion of the core
AD or mutations in the FYDVASAF motif resulted in signi-
ﬁcant loss of coactivator activity of CoCoA (assays 5–8).
This is consistent with the data observed in ER experiments
(Figure 8A). Thus, the core AD of CoCoA and its
FYDVASAF motif are required for its coactivator function
for GRIP1 and ER.
Previous studies have shown that CoCoA, p300 and
CARM1 interact with different domains of p160 coactivators
(AD3 for CoCoA, AD1 for p300 and AD2 for CARM1)
(5,6,8,15); and four coactivators, GRIP1, CoCoA, p300 and
CARM1, synergistically stimulate ER transcriptional activity
(15). We tested the activity of CoCoA mutants in transient
transfection assays using low-ER conditions, which facilitate
multiple coactivator synergy (Figure 8C) (10,15). In agree-
ment with a previous report (15), these four coactivators
synergistically enhanced ER function, and this synergy was
GRIP1-dependent (assays 4, 5, 12 and 14). Importantly, dele-
tion of CoCoA AD (CoCoA mutants 1–500 and 1–600)
severely reduced the synergy with p300, CARM1 and GRIP1
(assays 6, 8and15),while aCoCoA mutant (CoCoA 150–691)
lacking the N-terminal domain exhibited wild-type synergy
(assay 7). Note that all of the CoCoA deletion constructs
used in this experiment have an intact coiled-coil domain
and are capable of GRIP1 binding. CoCoA F628A and
D630P mutants also acted synergistically with GRIP1, p300
and CARM1, but with reduced efﬁcacy (assays 16–17). Inter-
estingly, the double mutation within the FYDVASAF motif,
F628/635A, resulted in nearly complete loss of transcriptional
activity (assay 18), which was comparable with that of CoCoA
1–600 (assay 15). These results suggest that, within the core
AD of CoCoA, two phenylalanines in the FYDVASAF motif
are critical for the synergy. In addition, these two phenylalan-
ine residues within the core AD are highly conserved in
CoCoA proteins of various species (Figure 7A).
p300 enhances GRIP1 AD3 activity through the
functional interaction with CoCoA
GRIP1 is believed to provide appropriate interaction surfaces,
AD3 and AD1, for recruitment of CoCoA and p300, respect-
ively, and the ﬁnding of direct physical interaction between
CoCoA and p300 suggested that CoCoA, p300 and GRIP1
might form a ternary complex. To test the idea that CoCoA
mediates the interaction between GRIP1 AD3 and p300 and
to investigate the functional consequence of p300 on the
activity of CoCoA, we tested the effect of p300 on the
CoCoA-dependent transcriptional AD (AD3, bHLH-PAS
domain) of GRIP1 in a mammalian one-hybrid system
(Figure 9). As expected, CoCoA efﬁciently enhanced the
transcriptional activation function of GRIP1 AD3 in a dose-
dependent manner (assays 5 and 7). p300 alone had no effect
on GRIP1 AD3 activity (assay 4), but in the presence of
CoCoA, p300 synergistically enhanced GRIP1 AD3 function
(assays 6 and 8). The dependence of p300 coactivator func-
tion for GRIP1 AD3 on CoCoA indicates that p300 associates
indirectly with GRIP1 AD3 through CoCoA. To test the
importance of the functional interaction between CoCoA
Figure 7. Helical FYDVASAF motif is important for the transcriptional ac-
tivity of CoCoA AD and its binding to p300. (A) Alignment of amino acid
sequences of the FXXFFXXF motif in the C-terminal AD of mouse, human
and rat CoCoAs. The well-conserved amino acids are indicated by boxes. (B)
Helicalwheelpresentationofresidues628–635ofCoCoA.(C)Mutationsinthe
FYDVASAF motif impair the transactivation activity of CoCoA AD. CV-1
cells in 12-well plates were transfected with GK1-LUC (200 ng) and plasmids
encoding Gal4 DBD, Gal4-CoCoA 470–691, or its mutants (200 ng), as
indicated. Luciferase activity was measured 48 h after transfection. Luciferase
activity results shown are from a single experiment which is representative of
threeindependentexperiments.(D)ExpressionlevelsofGal4-CoCoAproteins.
COS-7 cells were transfected with pM vectors encoding the indicated CoCoA
fragment. Cell extracts were subjected to immunoblot analysis with antibodies
against the Gal4 DBD. (E) p300 binding of CoCoA is greatly impaired by
mutations at phenylalanine residues in the FYDVASAF motif. GST pull-down
assays were performed using in vitro translated CoCoA or its mutant CoCoA
F628/635A and GST, GST-KIX or GST-CH3 bound to beads as in Figure 3F.
Nucleic Acids Research, 2006, Vol. 34, No. 9 2745AD and p300, we also tested the coactivator activity of
p300 in cooperation with a CoCoA deletion mutant lacking
the core AD. Neither CoCoA 1–600 nor both CoCoA
1–600 and p300 had a signiﬁcant effect on GRIP1 AD3
activity (assays 9–12). Thus, both the core AD of CoCoA
and the functional interaction between CoCoA and p300
are required for their synergistic coactivator function for
GRIP1 AD3.
DISCUSSION
Transcriptional activation is a dynamic process regulated by
protein–protein interactions that assemble, disassemble and
modulate a variety of DNA binding, coactivator, chromatin,
basal transcription factor and RNA polymerase complexes.
Characterizing these fundamental protein–protein interac-
tions and their regulation will provide a molecular basis for
Figure 8. The C-terminal AD is required for the NR coactivator activity of CoCoA. (A) CV-1 cells in 24-well plates were transfected with p2ERE-TATA-LUC
(100 ng), pHE0 encoding human ERa (1 ng), pSG5.HA-GRIP1 (100 ng) and pSG5.HA-CoCoA (+,100 ng; ++, 200 ng) or its mutants (100, 200 and 400 ng), as
indicated. Luciferase activity was measured 48 h after transfection. Luciferase activity results shown are from a single experiment which is representative of
three independent experiments. (B) CV-1 cells in 24-well plates were transfected with GK1-LUC(100 ng), plasmidsencoding Gal4 DBD or Gal4-GRIP1 (100 ng),
and pSG5.HA-CoCoA or its mutants (200 ng), as indicated. Luciferase activity was measured 48 h after transfection. Luciferase activity results shown are from a
single experiment which is representative of two independent experiments. (C) CV-1 cells in 24-well plates were transfected with p2ERE-TATA-LUC (100 ng),
pHE0encodinghumanERa(0.01ng),pSG5.HA-GRIP1(100ng),pSG5.HA-CARM1(100ng),pCMV-p300(100ng),andpSG5.HA-CoCoA(100ng)oritsmutants
(100 ng), as indicated. Luciferase activity was measured 48 h after transfection. Luciferase activity results shown are from a single experiment which is representa-
tive of three independent experiments.
2746 Nucleic Acids Research, 2006, Vol. 34, No. 9understanding how gene expression is regulated by a variety
of stimuli. In this study, we have characterized the C-terminal
AD of CoCoA and demonstrated that the coactivator CoCoA
directly interacts and functionally cooperates with p300 in
GRIP1- and ER-mediated transcription.
Transcriptionally important motifs in CoCoA AD
The C-terminal AD of CoCoA can be divided into several
subdomains, which appear to function synergistically: acidic
(amino acids 501–550, 601–630 and 660–680), S/P-rich
(amino acids 550–600 and 630–660) and F-rich (amino
acids 680–691) subdomains (Figure 1A). The core AD
(amino acids 601–691), which functioned as a minimal
autonomous transactivation domain (Figure 1B), could be
subdivided into two subdomains, acidic/S/P-rich region
(amino acids 601–660) and acidic/F-rich region (amino
acids 661–691). Although each subdomain by itself had
very little transcriptional activity, the combination of two
subdomains was capable of synergistically enhancing
transcriptional activation. It is possible that these two subdo-
mains recruit or activate different downstream coactivators to
synergistically stimulate transcription.
The acidic ADs of VP16 and p65 contain critical core
phenylalanine residues (24,25). We also found that two
phenylalanine residues in the FYDVASAF motif and the
F-rich region were critical for transcriptional activation by
CoCoA AD (Figures 1B and 7B). Mutations in the
FYDVASAF motif which resulted in signiﬁcant loss of trans-
activation by CoCoA AD and NR coactivator activity of
CoCoA also resulted in proportional loss of binding to
p300 (Figures 7 and 8). We conclude that the predicted hel-
ical motif, FYDVASAF, is an important functional motif of
CoCoA and that interaction between this motif and p300 is
required for transcriptional activation by CoCoA. However,
in addition to p300 it is also possible that this motif may
also interact with some other coactivators. In fact, the con-
served stretch of FXXFFXXF in the ADs of p53, VP16
and p65 can bind directly to TAF9 (a TATA box-binding
protein-associated factor previously referred to as TAFII31)
(26,38,39).
A CoCoA AD mutant lacking the C-terminal F-rich region
(amino acids 681–691) has very weak transactivation activity
(Figure 1B). Thus, the extreme C-terminal sequence of
CoCoA AD is critical for its transactivation function. This
F-rich sequence may be important to maintain the proper ter-
tiary structure of CoCoA AD or it may be important for bind-
ing other cellular factors. In view of the fact that mutants
lacking this sequence still bind to p300 (Figure 3 and data
not shown), and p300 still enhances transcriptional activities
of the mutants (Figure 4A), it is more likely that the sequence
may be important to recruit other transcriptional activators
that are required for its strong transactivation function. In
fact, several short fragments (amino acids 601–691, 601–
680 and 680–691) of CoCoA AD also behave as potent trans-
activating elements in yeast cells, which possess neither p300
nor CBP (data not shown). Additional, as yet unidentiﬁed,
coactivators must act through these small regions of
CoCoA AD to enable p300-dependent and independent trans-
activation. Therefore, an important issue in understanding the
function of the F-rich region is to identify speciﬁc target
molecules for the F-rich region.
Although amino acids 501–600 showed no signiﬁcant
transactivation potential (Figure 1B), this region could inter-
act weakly with p300 (Figure 3D) and was required for the
optimal transcriptional activity of CoCoA AD (Figure 1B).
Thus, amino acids 501–600 apparently harbor other critical
motifs or structures which cannot activate transcription
alone but can enhance the activity of the core AD. Analysis
of the amino acid sequence of CoCoA AD showed that it is
rich in proline residues, much like the transcriptional ADs of
other well characterized transcriptional activators including
p53 (41,42). A recent study showed that the proline repeat
motifs (PXXPXXP or PXPXXP) of the ADs of p53 and
Smad4 bind directly to p300 and are required for maximal
transcriptional activity (41). Two proline repeat motifs,
564-PPGPREP-570 and 579-PAPIAP-584, actually reside
within amino acids 501–600, suggesting that these motifs
may function as additional p300 contact sites.
The CoCoA AD is serine-rich. The prediction of phos-
phorylation sites of CoCoA AD by the NetPhosK 1.0 server
(43) indicated that it contains putative phosphorylation sites
for multiple kinases, such as mitogen-activated protein
kinases (MAPKs), casein kinases (CKs), protein kinase
A (PKA) and protein kinase C (PKC). Immunoprecipitation
assays with anti-phosphoserine antibodies indicated that this
region was phosphorylated (data not shown). The human
CoCoA was recently described to be an in vitro substrate of
p42 MAPK and of CDK2/Cyclin E (44). It remains to be
determined whether phosphorylation of the CoCoA AD by
the various kinases may differentially inﬂuence CoCoA
coactivator activity.
p300 functionally interacts with CoCoA AD
Our results indicated that the coactivator p300 and its HAT
activity are involved in CoCoA AD-mediated transactivation.
Figure9.Coactivatorfunctionofp300forGRIP1AD3dependsonthepresence
of CoCoA. CV-1 cells in 24-well plates were transfected with GK1-LUC
(100 ng), plasmids encoding Gal4 DBD or Gal4-GRIP1N (amino acids
5–479) (100 ng), pCMV-p300 (100 ng), and pSG5.HA-CoCoA or pSG5.HA-
CoCoA 1–600 (+,100 ng; ++, 200 ng), as indicated. Luciferase activity was
measured 48 h after transfection. Luciferase activity results shown are from a
single experiment which is representative of three independent experiments.
Nucleic Acids Research, 2006, Vol. 34, No. 9 2747Substantial HAT activity was associated with CoCoA and
CoCoA AD (Figure 2A) and CoCoA interacted with p300
in vitro and in vivo (Figure 2 and Figure 3), but not with
PCAF (data not shown). Thus, p300 might be the
predominant CoCoA AD-associated HAT. CoCoA AD
recruited endogenous p300 to the promoter region
(Figure 5). E1A, a p300 inhibitor, strongly repressed
CoCoA AD-mediated transcriptional activation and overex-
pression of p300 rescued E1A-mediated repression of
CoCoA AD activity (Figure 4). Moreover, an E1A mutant
lacking p300 binding domain failed to repress CoCoA AD
activity. The mechanism by which p300 regulates the
activity of CoCoA AD is presumably through its acetyltrans-
ferase activity since p300 DHAT mutants failed to enhance
CoCoA AD activity. A growing list of transcriptional activat-
ors has been shown to be acetylated by p300 (45). In most
cases, acetylation is responsible for transcription stimulation
by enhancing DNA-binding activity or regulating protein–
protein interaction. We showed in the present study that
HDACs strongly repressed CoCoA AD activity, and TSA
treatment led to an increase in CoCoA AD activity
(Figure 6). We also found that CoCoA AD immunoprecipit-
ated from COS-7 cells was signiﬁcantly acetylated (J.H. Kim
and M.R. Stallcup, unpublished data). However, CoCoA AD
was not acetylated by p300 and PCAF in vitro. Thus we
believe that interaction of CoCoA with p300 is part of a
mechanism by which CoCoA alters chromatin structure or
the activity of other transcription factors or coactivators at
target gene promoters by recruiting p300. What acetyltrans-
ferases are responsible for the acetylation of CoCoA AD,
whether p300 can also acetylate CoCoA in vivo and whether
the acetylation of CoCoA AD affects the coactivator activity
of CoCoA remain to be determined.
Role of CoCoA in p160 coactivator complex
CoCoA acted synergistically in combination with p300 and
CARM1 in low-ER transient transfection assays, and this
coactivator synergy is entirely dependent on the presence
of GRIP1 (Figure 8C). These results are consistent with
the model that GRIP1 as a primary coactivator recruits mul-
tiple secondary coactivators which contribute synergistically
to ER-mediated transcription. The role of CoCoA in the
p160 coactivator complex is most probably multifunctional
through multiple protein–protein interactions (Figure 10).
The coiled-coil domain interacts with GRIP1, and CoCoA
AD interacts with p300/CBP and might help recruit or
potentiate the HAT activity of p300/CBP (Figure 5). The
formation of a ternary complex among GRIP1, p300 and
CoCoA and the ability of CoCoA to bind simultaneously
GRIP1 and p300 were strongly supported by mammalian
one-hybrid assays using the GRIP1 AD3 fragment fused to
Gal4 DBD (Figure 9). Moreover, p300 enhanced synergist-
ically GRIP1 AD3 activity only in the presence of CoCoA,
suggesting that p300 stimulated GRIP1 AD3 function by
the interaction with CoCoA. Because the deletion of core
AD eliminated the coactivator function of CoCoA and
p300 for GRIP1 AD3, the contribution of p300 to
CoCoA-p300 synergy was mediated by functional inter-
action between p300 and core AD of CoCoA. The core
AD of CoCoA is required for stimulation by p300
(Figure 4A) and is, by itself, capable of interacting with
p300 (Figure 3F). These ﬁndings are most consistent with
a direct action of p300 on the transactivation activity of
CoCoA AD or vice-versa.
Another possible explanation for the role of CoCoA AD in
p160 coactivator complex might be to potentiate transcrip-
tional cross talk between the basal transcriptional machinery
and p160 coactivator complex (Figure 10). Transcriptional
activation by acidic transcriptional ADs has been correlated
with their ability to interact with components of the general
transcription machinery. The acidic ADs of VP16 and p53,
for example, bind to several general transcription factors
including TFIIH, TFIIB, TAF9 and TBP (26,38,46–48). As
discussed above, the hydrophobic sequence FXXFFXXF,
which is known as a KIX binding motif in the acidic ADs
of VP16, p53 and p65, also makes direct contacts with
TAF9 (26,38,39). We also observed the interaction between
CoCoA and components of TFIID including TBP and
TAF9, and the core AD of CoCoA was required for these
interactions (data not shown). The exact binding sites and
physiological relevance of these interactions remains to be
determined.
Residual coactivator activities of CoCoA AD deletion and
point mutants in reporter gene assays (Figure 8) suggest
that other domain(s) of CoCoA may also contribute to the
maximal activation of p160 coactivator complexes. Our
recent study showed that the N-terminal domain of CoCoA
is essential to activate b-catenin-mediated transcription,
although it is dispensable for GRIP1-mediated transcription
(20). Furthermore, we showed that p300 directly interacts
with the N-terminal domain of CoCoA (Figure 3D and E).
These results suggest that there may be an additional tran-
scriptional AD in the N-terminus of CoCoA. It is also pos-
sible that the different ADs of CoCoA may be differentially
used depending on the interaction partners. The ﬂexibility
provided by multiple ADs and by multiple subdomains in
the ADs could make CoCoA a versatile transcriptional
coactivator.
Figure 10. The possible roles of CoCoA in the p160 coactivator complex.
DNA-bound NRs recruit GRIP1. The ADs, AD1, AD2 and AD3, of GRIP1
transmit the transactivation signal by recruiting secondary coactivators, p300,
CARM1 and CoCoA, respectively. CoCoA may contribute to transcriptional
activation for NRs by one or more of multiple mechanisms: facilitating or
stabilizing the p160 coactivator complex through the simultaneous interaction
with GRIP1 and p300, enhancing the HAT or coactivator activity of p300,
bridging between the p160 coactivator complex and basal transcription
factors such as TBP and TAF9, and recruiting currently unknown downstream
coactivators.
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